← Leaderboards
Shannon L Stott
Massachusetts General Hospital
$3,615,955
Attributed
$6,952,034
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,952,034 · 5
By mechanism
R01$4,250,199 · 3
U18$1,998,964 · 1
U01$702,871 · 1
Top collaborators
- Brian Vala Nahed6 shared
- Francesca Demichelis3 shared
- Genevieve Marie Boland2 shared
- Dolores Di Vizio2 shared
- Michael R Freeman1 shared
- Sidharth Venkata Puram1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Michelle L Dossett$4,107,485
- Mehmet Toner$56,861,630
- Ravi Amrit Madan$1,203,094
- Xiao Li$1,419,158
- Chi-Fu Yang$2,348,201
Others in their field
Other Emerging Leaders on “Laboratories”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$463,311,620
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$210,784,687
- Lynn Briscoe · Leidos Biomedical Research, Inc.$172,823,180
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Leonard Freedmand · Leidos Biomedical Research, Inc.$105,458,370
Research focus
LaboratoriesSamplingTechnologyMicrofluidic MicrochipsTranslatingBloodLiquid BiopsyParticleCohortTreatment ResponseMicrofluidic TechnologyMalignant NeoplasmsResponseTissuesTumorMicrofluidicsDiagnosisCellsBlood TestsExtracellular VesiclesProteinsGenomicsData SetSignal Transduction
Grant awards (13)
Validating the hybrid epithelial/mesenchymal state as a biomarker of treatment response and outcomes in head and neck cancer$702,871
U01 · FY2025 · DE
Clinical Translation of a Large Oncosome-Based Prostate Cancer Blood Test$480,986
R01 · FY2025 · CA
Clinical Translation of a Large Oncosome-Based Prostate Cancer Blood Test$135,000
R01 · FY2025 · CA
Precision imaging of the spatial regulators of the hybrid epithelial/mesenchymal state in head and neck cancer$701,699
R01 · FY2024 · DE · contact PI
Clinical Translation of a Large Oncosome-Based Prostate Cancer Blood Test$649,486
R01 · FY2024 · CA
Benchmarking the Sensitivity and Specificity of the Herringbone Microfluidic Device for Rare Particle Capture$26,857
R01 · FY2023 · CA · contact PI
Microfluidic Isolation and Characterization of SARS-CoV-2 and Virus Related Exosomes$999,104
U18 · FY2022 · TR · contact PI
A microfluidic blood-based test to monitor treatment response in glioblastoma$458,136
R01 · FY2022 · CA · contact PI
Microfluidic Isolation and Characterization of SARS-CoV-2 and Virus Related Exosomes$999,860
U18 · FY2021 · TR · contact PI
A microfluidic blood-based test to monitor treatment response in glioblastoma$454,640
R01 · FY2021 · CA · contact PI
A microfluidic blood-based test to monitor treatment response in glioblastoma$451,144
R01 · FY2020 · CA · contact PI
A microfluidic blood-based test to monitor treatment response in glioblastoma$437,611
R01 · FY2019 · CA · contact PI
A microfluidic blood-based test to monitor treatment response in glioblastoma$454,640
R01 · FY2018 · CA · contact PI